Lane Michael's Form 4 filing
IDEXX Laboratories IncIDXX · filed Nov 5, 2026
- Accession no.
- 0000874716-26-000143
- Filed
- Nov 5, 2026, 5:01 PM ET
- Trade date
- Nov 4, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.74M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lane MichaelCIK 0001740689 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Common Stock | SSaleDisposed | −242.944 | $687.85 | −$167,109.03 | 7,812 | Direct | |
| Nov 4, 2026 | Common Stock | SSaleDisposed | −2,059 | $689.70 | −$1,420,092.3 | 5,753 | Direct | |
| Nov 4, 2026 | Common Stock | SSaleDisposed | −1,677 | $687.46F2 | −$1,152,868.07 | 4,076 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold ranging from a low of $687.0701 to a high of $687.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.